Goss Wealth Management »

Citius Pharmaceuticals shares owned by Goss Wealth Management

Quarter-by-quarter ownership of Citius Pharmaceuticals (CTXR) shares owned by Goss Wealth Management from 13F filings

Historical chart of Goss Wealth Management investment in Citius Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Citius Pharmaceuticals held by Goss Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citius Pharmaceuticals by Goss Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $311 400 0.78
2025-09-30 $32k 25k 1.24
2025-06-30 $40k 25k 1.59

More positions owned by Goss Wealth Management

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Ishares Core MF Closed and MF Open (IVV)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Alphabet Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
SPDR S&P MF Closed and MF Open (SPY)
Walmart Common Stock (WMT)
Berkshire Hathaway Common Stock (BRK.B)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Meta Platforms Common Stock (META)
Visa Common Stock (V)

View all positions for Goss Wealth Management

Top funds holding Citius Pharmaceuticals

Heights Capital Management
Vanguard Group
Geode Capital Management
XTX Topco
Citadel Advisors
Susquehanna International
UBS Group
BlackRock
Northern Trust
Two Sigma Securities
LPL Financial
State Street Corporation
Two Sigma Investments
Scientech Research
Arkadios Wealth Advisors

View all funds holding Citius Pharmaceuticals